Thus, additionally to increasing IK1 density, suggested before to treat arrhythmia (51–53), we propose reduction of its inward rectification, e.g., by direct interaction with the channel or by reducing ornithine decarboxylase activity to lower polyamine levels, as therapeutic concept preventing PVCs. This evidence concerns the gene ODC1 and Arrhythmia.